102 related articles for article (PubMed ID: 1816867)
1. Clinical experience with two simple methods of measurement of 99mTc-methylene diphosphonate body retention in bone disease.
Reschini E; Ulivieri FM; Ortolani S
J Nucl Biol Med (1991); 1991; 35(3):123-30. PubMed ID: 1816867
[TBL] [Abstract][Full Text] [Related]
2. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
3. [Whole-body retention of 99mTc-methylene diphosphonate in skeletal diseases].
Zorn-Bopp E; Büll U; Münzing W; Lang P; Moser EA
Nuklearmedizin; 1983 Feb; 22(1):24-30. PubMed ID: 6223277
[TBL] [Abstract][Full Text] [Related]
4. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases.
Seto H; Futatsuya R; Ihara F; Kamei T; Furumoto N; Ishizaki Y; Hada M; Kakishita M
Radiat Med; 1984; 2(2):87-92. PubMed ID: 6240671
[TBL] [Abstract][Full Text] [Related]
5. Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate.
Rajapakse C; Thompson R; Grennan DM; Winston BM; Patel P; Nuttall PM; Murphy J; Weiss JB
Ann Rheum Dis; 1983 Apr; 42(2):138-41. PubMed ID: 6221703
[TBL] [Abstract][Full Text] [Related]
6. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
7. Determination of bone turnover by urinary excretion of 99mTc-MDP.
Thomsen K; Nilas L; Mogensen T; Christiansen C
Eur J Nucl Med; 1986; 12(7):342-5. PubMed ID: 3792363
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate whole body retention test: relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders.
Mosekilde L; Hasling C; Tågehøj Jensen PC; Tågehøj Jensen F
Eur J Clin Invest; 1987 Dec; 17(6):530-7. PubMed ID: 3123252
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of 24-hr whole-body retention of 99mTc-MDP with a thyroid uptake probe (author's transl)].
Seto H; Kakishita M; Futatsuya R
Radioisotopes; 1981 May; 30(5):263-7. PubMed ID: 6458840
[TBL] [Abstract][Full Text] [Related]
10. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
Fogelman I; Bessent RG; Turner JG; Citrin DL; Boyle IT; Greig WR
J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
[TBL] [Abstract][Full Text] [Related]
11. 99Tcm-MDP global skeletal uptake and markers of bone metabolism in patients with bone diseases.
Rubini G; Lauriero F; Rubini D; D'Addabbo A
Nucl Med Commun; 1993 Jul; 14(7):567-72. PubMed ID: 8355916
[TBL] [Abstract][Full Text] [Related]
12. 24 hour whole body retention of 99mTc-methylene-diphosphonate in the assessment of bone formation. Methodological evaluation, clinical applications and comparison with serum alkaline phosphatase and serum osteocalcin.
Hyldstrup L
Dan Med Bull; 1989 Sep; 36(4):349-58. PubMed ID: 2509145
[No Abstract] [Full Text] [Related]
13. Simultaneous measurements of twenty-four-hour whole-body retention of 47Ca-chloride and 99mTc-MDP: early differentiation of metabolic bone diseases in rat models.
Seto H; Ihara F; Futatsuya R; Kamei T; Kakishita M; Noda M
Nucl Med Biol; 1993 Apr; 20(3):337-42. PubMed ID: 8485493
[TBL] [Abstract][Full Text] [Related]
14. Bone turnover in healthy adults measured by whole body retention and urinary excretion of 99mTc-MDP. Normalization by bone mass.
Thomsen K; Gotfredsen A; Christiansen C
Scand J Clin Lab Invest; 1986 Oct; 46(6):587-92. PubMed ID: 3775244
[TBL] [Abstract][Full Text] [Related]
15. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
Hyldstrup L; McNair P; Ring P; Henriksen O
Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
[TBL] [Abstract][Full Text] [Related]
16. [Quantitative assessment of metabolic bone disease in rat models by dual tracer method].
Ihara F; Seto H
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):657-66. PubMed ID: 2798057
[TBL] [Abstract][Full Text] [Related]
17. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest.
D'Addabbo A; Rubini G; Mele M; Lauriero F
Nucl Med Commun; 1992 Jan; 13(1):55-60. PubMed ID: 1594171
[TBL] [Abstract][Full Text] [Related]
18. A refined method for assessing 99mTc-MDP whole body retention in prostate cancer patients.
Castronovo FP; Prout GR; Strauss HW; McKusick KA; Griffin PP
Int J Rad Appl Instrum B; 1987; 14(5):475-7. PubMed ID: 3667311
[TBL] [Abstract][Full Text] [Related]
19. Quantification of diphosphonate uptake based on conventional bone scanning.
Brenner W; Bohuslavizki KH; Sieweke N; Tinnemeyer S; Clausen M; Henze E
Eur J Nucl Med; 1997 Oct; 24(10):1284-90. PubMed ID: 9323270
[TBL] [Abstract][Full Text] [Related]
20. Isotope retention for assessment of bone turnover in involutional osteoporosis.
Passeri M; Palummeri E; Baroni MC; Quaini F; Quintavalla A; Barbagallo M; Franchini D; Ugolotti D
Clin Rheumatol; 1989 Jun; 8 Suppl 2():35-40. PubMed ID: 2788063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
